FPH · ASX

Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)

AU$31.95

 0.44 (1.396%)
ASX:Live
01/05/2025 12:20:49 PM
HALO Ords HALO Growth HALO Earnings Momentum HALO Capital Efficiency HALO 200 +5
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

FPH Overview

FPH Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Weak

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Strong

Quality

Capital Efficiency

Very Weak

Balance Sheet

Weak

About FPH

Website

Fisher & Paykel Healthcare Corporation Limited

Telephone

64.9.574.0100

Address

East Tamaki 15 Maurice Paykel Place Auckland 2013

Description

Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.

FPH Price Chart

Key Stats

Market Cap

AU$18.70B

PE

62.20

EV/EBITDA

34.4

Dividends Overview

DIV Yield

1.4%

Franking

N/A

Ex Dividend Date (est.)

05-Dec-24

Market Data

52 weeks range

Low 25.3 - 35.76

Trade Value (12mth)

AU$3,489,066.00

1 week

-0.25%

1 month

1.71%

YTD

-9.04%

1 year

23.57%

All time high

35.76

Key Fundamentals

EPS 3 yr Growth

-75.20%

EBITDA Margin

27.50%

Operating Cashflow

$398m

Free Cash Flow Return

23.10%

ROIC

7.10%

Interest Coverage

26.50

Quick Ratio

1.00

Other Data

Shares on Issue (Fully Dilluted)

589m

HALO Sector

Healthcare

Next Company Report Date

28-May-25

Ex Dividend Date (est.)

05-Dec-24

Next Dividend Pay Date (est.)

18-Dec-24

Reporting Currency

AUD

Short Sell (% of issue)

0.19

FPH Announcements

Latest Announcements

Date Announcements

30 April 25

FPH announces 2025 Investor Event in Melbourne

×

FPH announces 2025 Investor Event in Melbourne

14 April 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

10 April 25

FPH to announce full year results on 28 May 2025

×

FPH to announce full year results on 28 May 2025

09 April 25

Change in substantial holding

×

Change in substantial holding

07 April 25

Application for quotation of securities - FPH

×

Application for quotation of securities - FPH

07 April 25

Application for quotation of securities - FPH

×

Application for quotation of securities - FPH

07 April 25

Ongoing Disclosure Notices - Employee Share Purchase Scheme

×

Ongoing Disclosure Notices - Employee Share Purchase Scheme

03 April 25

Application for quotation of securities - FPH

×

Application for quotation of securities - FPH

03 April 25

New US tariffs announced today

×

New US tariffs announced today

12 March 25

FPH launches F&P Nova Nasal mask in NZ and AU

×

FPH launches F&P Nova Nasal mask in NZ and AU

11 March 25

Ongoing Disclosure Notices - Employee Share Purchase Plan

×

Ongoing Disclosure Notices - Employee Share Purchase Plan

06 March 25

FPH enters into construction contract for fifth NZ building

×

FPH enters into construction contract for fifth NZ building

04 March 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

28 February 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

21 February 25

Ongoing Disclosure Notice - Ordinary Shares

×

Ongoing Disclosure Notice - Ordinary Shares

17 February 25

Change in substantial holding

×

Change in substantial holding

04 February 25

Notification of cessation of securities - FPH

×

Notification of cessation of securities - FPH

03 February 25

Costs forecast to increase under new US tariff regime

×

Costs forecast to increase under new US tariff regime

06 January 25

Application for quotation of securities - FPH

×

Application for quotation of securities - FPH

19 December 24

Notification of cessation of securities - FPH

×

Notification of cessation of securities - FPH

13 December 24

Update - Dividend/Distribution - FPH

×

Update - Dividend/Distribution - FPH

03 December 24

Notification of cessation of securities - FPH

×

Notification of cessation of securities - FPH

03 December 24

Notification regarding unquoted securities - FPH

×

Notification regarding unquoted securities - FPH

28 November 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

28 November 24

Dividend/Distribution - FPH

×

Dividend/Distribution - FPH

FPH Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.62 0.39 0.21 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.61 0.39 0.21 Lock Lock Lock
     Growth % Lock Lock Lock Lock -27.8 -35.9 -46.5 Lock Lock Lock
     PE X Lock Lock Lock Lock 31.4 57.9 62.2 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 19.0 34.0 34.4 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.60 0.48 0.66 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.06 -0.23 -0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock -46.5 -19.1 37.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -0.3 -0.9 -0.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.44 0.43 0.45 Lock Lock Lock
     Growth % Lock Lock Lock Lock 4.9 -0.9 4.2 Lock Lock Lock
     Yield % Lock Lock Lock Lock 1.8 1.6 1.4 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 71 110 200 Lock Lock Lock
BPS $ Lock Lock Lock Lock 2.70 2.83 2.76 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 2.56 2.69 2.62 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.2 5.2 -2.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 580 582 586 Lock Lock Lock
Basic m Lock Lock Lock Lock 577 578 582 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 1,548 1,447 1,630 Lock Lock Lock
     Growth % Lock Lock Lock Lock -14.9 -6.5 12.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 516 552 641 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 955 862 982 Lock Lock Lock
     Growth % Lock Lock Lock Lock -16.3 -9.8 14.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 61.7 59.5 60.3 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 38 40 40 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 530 400 448 Lock Lock Lock
     Growth % Lock Lock Lock Lock -26.7 -24.6 12.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 34.2 27.6 27.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 90 90 106 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 440 310 342 Lock Lock Lock
     Growth % Lock Lock Lock Lock -31.7 -29.6 10.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 28.4 21.4 21.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 475 299 218 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 120 71 96 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 355 228 123 Lock Lock Lock
     Growth % Lock Lock Lock Lock -27.4 -35.8 -46.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 22.9 15.8 7.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 306 217 398 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 160 193 314 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -84 -10 -314 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -222 -180 -119 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 175 46 105 Lock Lock Lock
     Growth % Lock Lock Lock Lock -59.7 -73.8 127.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.1 0.0 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 269 113 75 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 1,952 2,059 2,092 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 81 116 85 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -172 23 98 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 396 421 479 Lock Lock Lock
Equity $m Lock Lock Lock Lock 1,556 1,638 1,613 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 1,637 1,754 1,698 Lock Lock Lock
     Growth % Lock Lock Lock Lock 10.4 7.2 -3.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 18.2 11.1 5.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 22.8 13.9 7.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 27.8 18.1 19.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 22.8 13.5 7.1 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 19.6 12.8 23.1 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock 114.8 65.5 26.5 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -0.3 0.1 0.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -11.0 1.4 6.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.9 2.7 1.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.7 1.4 1.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 32.7 15.6 11.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 108.6 80.2 112.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 8.2 7.1 6.8 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 2.0 1.7 2.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 2.9 3.2 5.6 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 3.2 2.8 1.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.8 0.7 0.8 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.8 0.7 0.8 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 30.7 20.6 13.4 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 24.4 14.5 10.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 25.2 23.7 43.7 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 18.2 11.1 5.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.3 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 22.8 13.9 7.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 28.9 -10.0 -114.3 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 6.6 -1.4 -8.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 178.9 210.1 179.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 44.8 51.3 53.9 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 223.7 261.4 233.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 27.5 27.6 21.3 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 196.2 233.8 211.8 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

05-Dec-24

DIV Yield

1.4%

Franking Level

N/A

DPSg

4.20%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.19%

Value ($M)

34

Prior Change

N/A

7 Day Change

N/A

1 Month Change

-0.10%

3 Month Change

-0.20%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

FPH Shortsell

Frequently Asked Questions

The current share price of Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is AU$31.95.
The 52-week high share price for Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is AU$35.76.
The 52-week low share price for Fisher & Paykel Healthcare Corporation Limited (FPH:ASX)? is AU$25.30.
The current TTM dividend payout for Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is 1.40.
The last dividend payment of Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is AU$0.20.
Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) has a franking level of 0.0%.
Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is classified in the Healthcare.
The current P/E ratio for Fisher & Paykel Healthcare Corporation Limited (FPH:ASX) is 62.20.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.